Medicine Man Technologies Inc (SHWZ)
0.5226
-0.04
(-6.91%)
USD |
OTCM |
May 21, 16:00
Medicine Man Technologies Profit Margin (Quarterly): -38.59% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -38.59% |
| December 31, 2023 | -67.78% |
| September 30, 2023 | -0.69% |
| June 30, 2023 | -15.59% |
| March 31, 2023 | 4.36% |
| December 31, 2022 | -68.10% |
| September 30, 2022 | 4.19% |
| June 30, 2022 | 76.45% |
| March 31, 2022 | -84.27% |
| December 31, 2021 | 48.39% |
| September 30, 2021 | 3.04% |
| June 30, 2021 | 14.22% |
| March 31, 2021 | -18.87% |
| December 31, 2020 | -107.4% |
| September 30, 2020 | -39.22% |
| June 30, 2020 | -121.6% |
| March 31, 2020 | -43.06% |
| December 31, 2019 | -103.4% |
| September 30, 2019 | -51.40% |
| June 30, 2019 | -501.9% |
| Date | Value |
|---|---|
| March 31, 2019 | -145.3% |
| December 31, 2018 | -256.9% |
| September 30, 2018 | |
| June 30, 2018 | 12.82% |
| March 31, 2018 | 2.10% |
| December 31, 2017 | -43.50% |
| September 30, 2017 | -52.32% |
| June 30, 2017 | -509.4% |
| March 31, 2017 | 20.54% |
| December 31, 2016 | -2.76K% |
| September 30, 2016 | 7.93% |
| June 30, 2016 | -66.55% |
| March 31, 2016 | -57.04% |
| December 31, 2015 | -20.16% |
| September 30, 2015 | 20.92% |
| June 30, 2015 | 24.19% |
| March 31, 2015 | 20.33% |
| December 31, 2014 | -1.01K% |
| September 30, 2014 | 60.07% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-501.9%
Minimum
Jun 2019
76.45%
Maximum
Jun 2022
-55.56%
Average
-38.90%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.20% |
| Return on Assets | -14.81% |
| Return on Invested Capital | -18.57% |
| Gross Profit Margin (Quarterly) | 43.11% |
| Operating Margin (Quarterly) | -6.51% |
| Return on Net Operating Assets | -16.25% |